 Edinburgh cohort HIV-positive drug users auditory event-related potentials progressive slowing patients Disease Control stage IV disease two-tone auditory event-related potential AEP task brain function HIV-positive individuals intravenous drug use years initial infection Multiple regression analysis AEP latency amplitude components small effects past medical psychiatric history current symptoms drug use electrophysiological responses HIV-positive patients latency reduced amplitude component AEP normal control group similar control group HIV-seronegative drug users amplitude patients Disease Control stage IV One-year follow-up patients significant lengthening latency patients stage IV disease stage II stage III disease results brain involvement HIV infection clinical diagnosis stage IV disease